Brief: Immuneering Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Business Updates
10/03/2022 11:34
March 10 (Reuters) - Immuneering Corp IMRX.O :
* IMMUNEERING REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATES
* Q4 LOSS PER SHARE $0.42
* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $150.2
MILLION IS EXPECTED TO PROVIDE CASH RUNWAY INTO Q3 2024
* Q4 EARNINGS PER SHARE VIEW $-0.39 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9yQKNW
Further company coverage: IMRX.O
Recent news on Immuneering
See all newsImmuneering expects cash runway to fund operations into 2029
Immuneering posts smaller-than-expected Q1 net loss on lower R&D spend
U.S. STOCKS ON THE MOVE-GoPro, Prudential Financial, Whitestone REIT
U.S. STOCKS ON THE MOVE-US airlines, BlackRock, copper miners
U.S. STOCKS ON THE MOVE-Gap, Caterpillar, Solid Biosciences